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The pediatric anti-viral immune response impairs neural stem/progenitor cell activity 
Yashika S. Kamte, Manisha N. Chandwani and Lauren A. O’Donnell 
Graduate School of Pharmaceutical Sciences, Duquesne University, Pittsburgh, PA-15282, USA 
1. INTRODUCTION: 
Viral infections of the brain are one of the major causes of central nervous system (CNS) disease. 
Although the brain is well protected by the blood brain barrier, neurotropic viruses can gain entry into the 
brain via many routes like retrograde transport through motor and olfactory neurons, direct infection of 
the endothelial cells, and by crossing the blood brain barrier [1]. Several viruses like measles virus (MV), 
cytomegalovirus (CMV), lymphocytic choriomeningitis virus (LCMV), herpes simplex virus (HSV) enter 
the brain and cause disease. Some of the pathological outcomes of these viral infection are immediate 
(e.g. meningitis and encephalitis), while conditions like epilepsy, blindness, hearing loss, and cognitive 
deficits occur subsequently [1, 2]. Neurotropic infections can also lead to neuropsychiatric dysfunction 
like memory loss, bipolar disorder, schizophrenia, and hallucinations [2].  
The age of the host plays an important role in the outcome of CNS disease. Neurotropic infections 
may impair brain development if it occurs in the prenatal and postnatal stages [1, 3-6]. A number of 
animal models have been shown to recapitulate this age-dependent pathology during neurotropic 
infections [5, 7]. Sindbis virus, MV, LCMV, and borna disease virus (BDV) induce mortality in neonates 
while adults survive the infection [5, 8-10]. Although majority of the brain development occurs in the 
fetal and neonatal periods, developmental processes are ongoing in the pediatric age. In humans, the brain 
reaches 90-95% of its adult size by ~3 years of age, which corresponds to post-natal day 21 (P 21) in a 
rodent. Development of the prefrontal cortex, synaptogenesis, and pruning occurs majorly from pediatric 
to juvenile phase in humans and rodents [11, 12]. Additionally, the immune system also continues to 
develop postnatally. The two major arms of the immune response (innate and adaptive) mature with age 
[13]. As such, neonates have limited capability to mount a robust immune response to infections 
compared to adults. In rodents, peak antigen responsiveness and changes in the adaptive immune system 
has been shown to occur between postnatal week 2-3 [14-16]. Thus, a CNS viral infection during this 
period could lead to substandard immune response that might fail to control the infection and ultimately 
affect CNS development. 
Neural stem/progenitor cells (NSPCs) are the multipotent progenitor cells of the CNS, which 
differentiate to form neurons, astrocytes, and oligodendrocytes. With age, the NSPC pool becomes 
restricted to two neurogenic niches of the brain, namely the hippocampus and the sub-ventricular zone 
(SVZ) [17, 18]. In the hippocampus, the NSPC pool is involved in neurogenesis that helps continue 
memory and learning process while in the SVZ, the NSPC pool plays a role in olfaction [19, 20]. CMV, 
HSV, West Nile virus (WNV), LCMV, MV, BDV, and rabies virus are known to impact NSPC activity 
either by inhibiting their proliferation or altering their differentiation [2, 21-23]. As NSPCs are 
responsible for formation of neurons and glia, impairment of NSPC activity can impact overall 
neurogenesis and gliogenesis. This impairment in the hippocampus might impact memory and learning. 
This alteration in NSPC activity can be direct; where viruses infect NSPCs or indirect; via the anti-viral 
immune response. Our lab focuses on the indirect impact of viral infections on the NSPCs.  
In the current study, our goal was to define the impact of a pediatric anti-viral immune response 
on NSPCs. To accomplish this, we used the transgenic CD46+ mouse model. In this model, the human 
isoform of the MV receptor CD46 is under the control of a neuron-specific enolase (NSE) protomer and is 
expressed only on mature neurons. Hence, only the neurons are infected in our model [24]. Thus, any 
alteration in NSPC activity will be due to the anti-viral immune response and not the infection itself. 
Using this model of CNS infection, we show that the NSPC pool is significantly reduced in the pediatric 
hippocampus and SVZ during an active viral infection. 
2. METHODS AND MATERIALS: 
2.1 Animals and ethics statement: 
Mice were maintained and treated in accordance with the Institutional Animal Care and Use 
Committee of Duquesne University and the NIH Guide for the Care and Use of Laboratory Animals. 
CD46+ mice (a gift from Dr. Glenn Rall; Fox Chase Cancer Center, Philadelphia, PA) were maintained 
on a 12:12 light/dark cycle under controlled temperature conditions (20±2°C) with free access to food and 
water. Mating pairs were established for CD46+ mice in order to generate pediatric pups for our 
experiments.  
2.2 Measles virus infection: 
CD46+ mice were infected with MV-Edmonston obtained from the ATCC (American Type 
Culture Collection, Cat. No: VR-24). The virus was passaged thrice in Vero fibroblasts. The inoculum 
was diluted to 10,000 plaque forming units (PFU)/10µl with phosphate-buffered saline (PBS).  
On postnatal day 10 (P10), pediatric mice were injected intracerebrally (IC) with MV (either 
20,000 or 40,000 PFU) with a 1 cc syringe and 27½ gauge needle. The uninfected control group was 
infected with 20µl PBS at the same anatomical location. The pups were monitored daily for any signs of 
illness (ruffled fur, hunched poster, problems with movement and weight loss) and survival up to 90 days 
post infection (dpi).  
2.3 Flow cytometric analysis for neural cells: 
At the indicated dpi, pediatric mice were deeply anesthetized using isoflurane. The whole brains 
were harvested, and the hippocampus and SVZ were dissected. These brain regions were then processed 
to obtain a single cell-suspension. Briefly, the hippocampi and SVZ were incubated for 30 mins at 37°C 
in an enzyme mixture containing 15 U/ml papain, 1 U/ml dispase, 5mM L-cysteine and 1mM of DNase. 
The tissue was mechanically dissociated by pipetting 15-20 times in 500µl of Dulbecco’s Modification of 
Eagle’s Medium (DMEM) and incubated for 10 mins to allow for undissociated tissue to settle at the 
bottom. Then, 400µl of the supernatant was collected, and again subjected to mechanical dissociation in 
an additional 400µl DMEM. After allowing the sample to stand for 10 mins, 700µl of the supernatant was 
collected and centrifuged to obtain a pellet of single cell isolates. The single cell isolates were then fixed 
with Cytoperm/Cytofix solution for 30 mins at 4°C in dark. The fixed cells were stained with the 
following antibodies for 1 hour at 4°C: Alexa Fluor 647-Nestin (1:1), PE-Doublecortin (DCX) (1:10), βIII 
tubulin (1:50), GFAP (1:50), A2B5 (1:10) and Alexa Fluor 488-secondary goat anti-rabbit (1:1000). The 
cells were then analyzed on Attune NxT. For each panel of antibodies, 1x106 events were counted. Gating 
was applied based on Fluorescent Minus One (FMO) which were used as staining controls as described 
previously [25, 26].  
2.4 Flow cytometric analysis for immune cells: 
After dissecting the hippocampus and SVZ as mentioned above, the rest of the brain was 
processed to detect the immune cells infiltrating the brain during infection. Briefly, the remaining brain 
tissue was passed through a nylon mesh cell strainer in PBS. The dissociated tissue was run over a 
30/70% discontinuous Percoll gradient for 20 mins at room temperature. Mononuclear cells were 
collected from the interface, washed with PBS, and then treated with 0.84% ammonium chloride to 
remove contaminating red blood cells (RBCs), and washed again in PBS. Primary antibodies were 
applied in 1% fetal bovine serum (FBS) in PBS for 1 hour in dark at 4°C. The following antibodies were 
used to identify T cells: APC CD8a (600ng/ml), FITC CD19 (600ng/ml), PE CD4 (600ng/ml), and 
PerCP-CY™ 5.5 CD3 Molecular complex (600ng/ml). To identify NK cells, APC NK1.1 (600ng/ml), PE 
CD49b (600ng/ml), PerCP-CY™ 5.5 CD3 Molecular complex (600ng/ml), and FITC CD19 (600ng/ml) 
were used. To identify neutrophils, PerCP CD45 (1:50), APC CD11b (1:50), FITC Ly6G (1:50), and PE 
F4/80 (1:50). As described above, the stained cells were analyzed on Attune NxT. Gating was applied 
based on FMO using splenocytes. Single antibody stains were used for color compensation. 
2.5 Statistical analysis:  
Statistical analysis for the Kaplan-Meier plots was done by log rank test to compare the survival 
rate between infected and uninfected groups. Two-way Student t-test was done to compare between 
neural cells and immune cells between infected and uninfected mice. Pearson’s correlation test was used 
to understand if NSPC numbers correlate with immune cell infiltration. Differences were significant when 
the p value was less than 0.05. All graphs and statistical analysis were done using GraphPad Prism 
software.  
3. RESULTS: 
3.1: Pediatric mice develop neurological symptoms and succumb after MV infection: 
To understand the impact of a CNS viral infection during the pediatric age, we used a neuron-
restricted MV infection model [24]. Previous studies in our model have shown that neonates succumb to 
the infection, while the adults survive [5, 27, 28]. The infected neonates also showed severe CNS disease 
while the adults do not show any signs of sickness during the infection [5, 29]. The impact of viral 
infections can be disastrous even during the pediatric age group. However, not much is known about the 
pathology of neurotropic infections in them. Thus, we aim to characterize a pediatric model to study the 
neuropathological impacts of a CNS viral infection which is still understudied. To study this, we injected 
either 20,000 PFU MV or 40,000 PFU MV intracranially at post-natal day 10 (P10). The animals were 
monitored for any sickness (e.g. ataxia, seizures) till 90 days post infection (dpi). As shown in Fig. 1, 
survival was dose-dependent, where the pups infected with the high dose (40,000 PFU of MV) showed 
75% mortality while those infected with the low dose (20,000 PFU of MV) showed 22% mortality. Death 
occurred between 10-15 dpi and 7-15 dpi for pups infected with 20,000 PFU MV and 40,000 PFU MV 
respectively. Regardless of the viral inoculum, mice that reached 16 dpi survived until 90 dpi. The sick 
pups showed varying degree of symptoms, ranging from crusty eyes, ruffled fur, hunched posture, and 
tremors. The control group, which was injected with an equivalent volume of PBS, did not show any 
signs of illness or weight loss throughout the study. Based on these findings, we selected 20,000 PFU MV 
as the dose for future pediatric studies, as this group showed some degree of pathology while also having 
a group of survivors for our long-term studies. Overall, our survival studies showed that a CNS viral 
infection in the pediatric age groups is associated with mortality rate between that of the neonates and the 
adults. 
 
Figure 1. MV infection in the CNS of pediatric mice shows dose-dependent survival: Kaplan-Meier plot of pediatric (P10) mice after MV 
infection or PBS to 90 days post infection (dpi). Log rank test was used to compare between infected and control groups. The PBS injection mice 
(black line) shows 100% survival (n=18). Pups injected with a low dose of virus (20000 PFU MV, purple line) showed 78% survival (p=0.0381, 
n=23). Pups injected with a high dose of virus (40,000 PFU MV, red line) showed 25% survival (p<0.0001, n=7). Neonates injected with 10,000 
PFU MV succumb to the infection (light blue line) by 12 dpi (p<0.0001, n=8), as supported by our prior studies. 
3.2 Innate and adaptive immune cells infiltrate the brain early during infection 
The anti-viral immune response has been viewed as central to viral clearance and control in the 
CNS [30-34]. Earlier studies in MV infected CD46+ adults have shown that infiltrating immune cells 
from the periphery are important for viral control. Specifically, CD4+ T cells along with CD8+ T cells or 
B cells were seen to be of prime importance in controlling the viral load in the infected adults [29]. In 
neonates, the CD4 T cell population is low in the brain during infection, which is believed to contribute to 
the failure of viral control in newborns. To determine the immune cell profile at the pediatric age, we 
carried out flow cytometry to determine the innate and adaptive immune cells infiltrating the brain. We 
selected 9 dpi as our time point in early infection for the following reasons: (a) at this time point, we 
could distinguish between sick and non-sick pups in the group and (b) mortality occurred mainly from 10-
15 dpi. We observed that both the innate and adaptive immune cells infiltrated the brain at 9 dpi. As seen 
in Fig. 2, significant differences were seen in innate immune cells [e.g. macrophage/microglia 
(****p<0.0001), NK cells (**p=0.0006), neutrophils (***p=0.0002)] and adaptive immune cells [CD4+ 
T cells, CD8+ T cells and B cells (****p<0.0001)] in the infected group compared to the PBS group. 
Thus, we observed that early during infection both the innate and adaptive immune system is active in the 
CNS.  
 
Figure 2. Innate and adaptive immune cells infiltrate the brain at 9 dpi: Whole brain tissue (with the hippocampus and the SVZ removed for 
neural cell flow cytometry) was processed to obtain a single cell suspension and analyzed for both innate and adaptive immune cells. 
Macrophage/microglia (2A) in the MV infected brain was significantly increased compared to PBS (****p<0.0001). Neutrophils (2B) and NK 
cells (2C) also showed significantly higher infiltration in the MV infected animals than PBS (***p=0.0002, and ***p=0.0006). Along with innate 
immune cells, at 9 dpi, adaptive immune cells such as CD4+ T cells (2D), CD8+ T cells (2E), and B cells (2F) were also significantly increased 
in the infected group (****p<0.0001). Two-way student t-test was used for statistical comparison (n=17-19). Both male and female, as well as 
sick and non-sick animals, were included together.  
 3.3 NSPC pool decreases in pediatric mice early during infection 
The brain is under ongoing development during the pediatric age in both humans and rodents [11, 
35-37]. Thus, we hypothesized that CNS viral infection at this stage might impact the developing neural 
cells. We examined the number of NSPCs, neurons, and astrocytes in infected and uninfected pediatric 
mice using flow cytometry. The hippocampus and SVZ were analyzed separately to account for the main 
neurogenic niches in adulthood [17]. In the hippocampus, we observed that NSPCs (Fig. 3A, nestin+) and 
immature neurons (Fig. 3B, DCX+) showed a significant decrease with infection (****p<0.0001 and 
***p=0.0002). We did not see any differences in mature neurons, immature glia, or astrocytes during 
infection. Similarly, in the SVZ, we saw a significant reduction in the NSPC pool (Fig. 4A, nestin+) in 
the infected group (p<0.0001). Immature glia (Fig. 4D, A2B5+) showed a significant increase in the MV 
infected group compared to the PBS group (*p=0.0433). We did not observe any differences in immature 
neurons, and astrocytes. Mature neurons (Fig. 4C, β-III tubulin+) showed a trend towards increase in the 
infected compared to the uninfected group (p=0.0542). Our studies indicate that at 9 dpi in the pediatric 
age, there is a significant contraction in NSPC pool in both the hippocampus and the SVZ. Since only 
neurons are infected in this model, we propose that the decline in the NSPCs is due to the anti-viral 
immune response, as opposed to direct infection by the virus [24].  
 Figure 3. Hippocampal NSPC pool decreases during pediatric CNS infection: At 9 dpi, the hippocampi from the brains of the infected and 
uninfected pups were processed for flow cytometry for various neural cell markers. A significant decrease in Nestin+ cells (NSPCs- 3A) and in 
DCX+ cells (immature neurons- 3B) was seen in the infected group compared to the uninfected group (****p<0.0001 and ***p=0.0002). No 
differences were seen in β-III tubulin+ (mature neurons- 3C), A2B5+ (immature glia- 3D), and GFAP+ (astrocytes- 3E). Student t-test was used. 
For these experiments n=13-19 and both male and female and sick and non-sick animals were included.  
 Figure 4. SVZ NSPC pool decreases during pediatric CNS infection: At 9 dpi the SVZ from the brains of the infected and uninfected pups 
were processed for flow cytometry for various neural cell markers.  A significant decrease in Nestin+ cells (NSPCs- 4A) was seen in the infected 
compared to the uninfected group (****p<0.0001). A2B5+ cells (immature glia- 4D) also showed a significant increase in the infected group 
(*p=0.0433). β-III tubulin+ cells (mature neurons- 4C) showed an increase in the MV infected group which was trending towards significance 
(p=0.0542). No differences were seen in DCX+ cells (immature neurons- 4B) and GFAP+ (astrocytes- 4E). Student t-test was used. For these 
experiments n=13-19 and both male and female and sick and non-sick animals were included.  
3.4 The decrease in NSPC pool correlates with the infiltration of immune cells at 9dpi 
As we observed an active immune response and a decrease in NSPC pool at the same time, we 
wanted to understand if the decrease in NSPC pool correlates with the infiltration of specific immune 
cells in the brain at 9 dpi. A Pearson’s correlation test was used for this purpose. The hippocampus 
showed (Fig. 5), a strong negative correlation between NSPCs and macrophage/microglia (R2=0.5453, 
p<0.0001), neutrophils (R2= 0.3013, p=0.0055), CD4+ T cells (R2= 0.5691, p<0.0001), CD8+ T cells 
(R2= 0.3293, p=0.0065), and B cells (R2= 0.5811, p<0.0001). We saw a similar negative correlation 
between NSPC pool and immune cells in the SVZ (Fig. 6). Specifically, Macrophage/microglia (R2= 
0.6132, p<0.0001), neutrophils (R2=0.2617, p=0.0106), CD4+ T cells (R2= 0.5230, p<0.0001), CD8+ T 
cells (R2= 0.4653, p=0.0007) and B cells (R2= 0.5607, p<0.0001). Thus, we observed that with the 
increasing infiltration of immune cells, the NSPC pool decreases in both the hippocampus and the SVZ at 
this age.  
 
Figure 5. Hippocampus shows negative correlation of NSPCs and immune cells: Pearson’s correlation between NSPCs and immune cells in 
the hippocampus of uninfected (blue) and MV-infected (red) pediatric mice. Negative correlations between NSPCs and immune cells were found 
with macrophage/microglia (R2=0.5453, p<0.0001- 5A), neutrophils (R2= 0.3013, p=0.0055- 5B), CD4+ T cells (R2= 0.5691, p<0.0001- 5D), 
CD8+ T cells (R2= 0.3293, p=0.0065- 5E) and B cells (R2= 0.5811, p<0.0001- 5F). 
 
 Figure 6. SVZ shows negative correlation of NSPCs and immune cells: Pearson’s correlation between NSPCs and immune cells in the SVZ of 
uninfected (blue) and MV-infected (red) pediatric mice. Negative correlations between NSPCs and immune cells were found with 
macrophage/microglia (R2= 0.6132, p<0.0001- 6A), neutrophils (R2=0.2617, p=0.0106- 6B), CD4+ T cells (R2= 0.5230, p<0.0001- 6D), CD8+ T 
cells (R2= 0.4653, p=0.0007- 6E) and B cells (R2= 0.5607, p<0.0001- 6F).  
4. DISCUSSION:   
In this study, we have characterized an in vivo model of neurotrophic pediatric infection, where 
we observe neuropathology along with NSPC loss. This model will allow us to follow survivors of 
pediatric infections into adulthood in order to carry out long-term studies. We have previously seen that 
neonates succumb to MV infection while adults show 100% survival [5]. Here, we show that the pediatric 
mice have a survival rate that is intermediate between the neonates and adults. This reflects that the age of 
the host has a crucial influence on the outcomes of a CNS viral infection, and that potential development 
of both the brain and immune response in childhood can confer partial protection against viral infection. 
We showed that the pediatric anti-viral immune response leads to a decrease in NSPC pool in the 
hippocampus and the SVZ. We hypothesize that this might be due to cell death, inhibition of 
proliferation, or a change in NSPC phenotype where they no longer express nestin. In adulthood, the 
hippocampus and the SVZ are the neurogenic niches of the brain that are responsible for adult 
neurogenesis. In the hippocampus, NSPCs are localized in the sub-granular zone (SGZ) where their 
function is to give rise to new neurons that migrate and integrate into the existing circuitry of the dentate 
gyrus (DG). Hippocampal neurogenesis in the adulthood is mainly responsible for learning, social 
behavior, and memory processes [19, 38, 39]. The decrease in the hippocampal NSPC pool at 9 dpi was 
maintained even at 90 dpi (data not shown). Therefore, a decrease in the hippocampal NSPCs at a young 
age could not only alter total cell population in the adult brain but also lead to deficits in memory and 
cognition in adulthood. At 9 dpi, we also saw a reduction in the immature neuron (DCX+) population, 
which could reflect a decrease in neurogenesis and potential memory impairment in adulthood.  
In the pediatric SVZ, we saw a decrease in NSPC pool at 9 dpi (Figure 4) and at 90 dpi (data not 
shown). The NSPCs in the SVZ are different functionally from that in the hippocampus. From the SVZ, 
newly formed neurons migrate via the rostral migratory stream (RMS) to the olfactory bulb (OB), which 
is responsible for olfaction and olfactory memory [19, 20]. A depletion in the NSPC pool here might lead 
to impairment of olfaction. In the SVZ, we also saw an increase in immature glia (A2B5+), which implies 
an increase in gliogenesis early in infection. As the neurons in our model are being infected, this increase 
could be a protective mechanism to prevent more neurons from getting infected and thus contain viral 
infection.  
Apart from the changes in the neural cell populations, we also saw significant increases in the 
infiltration of innate (NK cells, neutrophils, and macrophage/microglia) and adaptive (CD4, CD8, and B 
cells) immune cells. Previous studies in our model have seen that CD4+ T cells are imperative for 
controlling viral spread in conjunction with B cells or CD8+ cells [29]. Thus, we wanted to understand if 
immune cell infiltration correlate with NSPC numbers. We saw a negative correlation between NSPC 
numbers and immune cells in the pediatric CNS in early infection. One potential explanation for the 
decrease in the NSPC pool during increased immune cell infiltration could be the inflammatory milieu. 
Although anti-viral cytokines (e.g. IFNγ) are critical to control the viral spread, they also have been 
shown to inhibit NSPC proliferation, which might decrease NSPC pool [40-42]. Since the NSPCs are not 
infected by MV, our findings suggest that the pediatric anti-viral immune response reduces the NSPC 
pool for an extended period of time. This contraction in NSPC numbers could be a protective or 
pathological. A potential protective response could be to keep NSPC damage to a minimum during active 
infection, or that the loss of NSPCs is purely a pathological outcome with no protective consequences for 
the host.  
Our future studies aim at answering the outstanding question about the long-term impact of 
pediatric neurotropic infection on neural cells and behavior. 
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